INDV · Indivior Pharmaceuticals, Inc. · Documents

$35.25 +0.48 (+1.38%)

Market Cap

$4.10B

118.01M

Volume · Oct 20 1.93M Avg daily vol (3M) 2.3M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2024-03-12	—
6-K	—	2024-03-11	—
6-K	—	2024-03-11	—
6-K	—	2024-03-08	—
6-K	—	2024-03-08	—
6-K	—	2024-03-07	—
6-K	—	2024-03-07	—
6-K	—	2024-03-06	—
6-K	—	2024-03-06	—
6-K	—	2024-03-06	—
6-K	—	2024-03-06	—
20-F	—	2024-03-06	2023-12-31
6-K	—	2024-03-06	—
6-K	—	2024-03-05	—
6-K	—	2024-03-04	—
6-K	—	2024-03-04	—
6-K	—	2024-03-04	—
6-K	—	2024-03-01	—
6-K	—	2024-03-01	—
6-K	—	2024-02-29	—
6-K	—	2024-02-29	—
6-K	—	2024-02-27	—
6-K	—	2024-02-22	2023-12-31
6-K	—	2024-02-22	—
6-K	—	2024-02-21	—
6-K	—	2024-02-20	—
6-K	—	2024-02-20	—
6-K	—	2024-02-16	—
6-K	—	2024-02-15	—
6-K	—	2024-02-14	—
6-K	—	2024-02-13	—
6-K	—	2024-02-12	—
6-K	—	2024-02-09	—
6-K	—	2024-02-08	—
6-K	—	2024-02-07	—
6-K	—	2024-02-06	—
6-K	—	2024-02-05	—
6-K	—	2024-02-02	—
6-K	—	2024-02-01	—
6-K	—	2024-02-01	—
6-K	—	2024-01-31	—
6-K	—	2024-01-30	—
6-K	—	2024-01-30	—
6-K	—	2024-01-29	2024-01-26
6-K	—	2024-01-29	—
6-K	—	2024-01-25	—
6-K/A	—	2024-01-25	—
6-K	—	2024-01-23	—
6-K	—	2024-01-22	—
6-K	—	2024-01-19	—

Showing 251–300 of 386 filings

Key facts CIK 1625297 CUSIP 45579U109 13F (30d) 32 filings 32 filers Visit website Investor relations